PCSK9 drives acquired resistance to anti-PD-1 immunotherapy through cystine metabolic reprogramming in lung cancer.

Authors

Guangling Jie, Zhengqi Cao, Jingze Wang, Wenqing Lu, Xiaokuan Zhu, Ziming Li, Ying Wang, Shun Lu, Liliang Xia

Published in

Journal for immunotherapy of cancer. Volume 14. Issue 10. Oct 20, 2026. Epub Oct 20, 2026.

PMID:
42901717
Bibliographic data and abstract were imported from PubMed on 21 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.